Response to Comment on “Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin”

被引：0
|
作者：
Morganne Sindelar
Daniel McCabe
Elisabeth Carroll
机构：
[1] The University of Iowa Hospitals & Clinics,Division of Medical Toxicology, Department of Emergency Medicine
[2] The University of Iowa Hospitals & Clinics,undefined
来源：
Journal of Medical Toxicology | 2023年 / 19卷
关键词：
Drug-drug interaction; Tacrolimus; Nirmatrelvir/ritonavir;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：309 / 309
相关论文
共 50 条
  • [1] Response to Comment on "Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin"
    Sindelar, Morganne
    McCabe, Daniel
    Carroll, Elisabeth
    JOURNAL OF MEDICAL TOXICOLOGY, 2023, 19 (03) : 309 - 309
  • [2] Comment on "Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin"
    de Oliveira, Luciana Mello
    Dal Pizzol, Tatiane da Silva
    JOURNAL OF MEDICAL TOXICOLOGY, 2023, 19 (03) : 307 - 308
  • [3] Comment on “Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin”
    Luciana Mello de Oliveira
    Tatiane da Silva Dal Pizzol
    Journal of Medical Toxicology, 2023, 19 : 307 - 308
  • [4] Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin
    Sindelar, Morganne
    McCabe, Daniel
    Carroll, Elisabeth
    JOURNAL OF MEDICAL TOXICOLOGY, 2023, 19 (01) : 45 - 48
  • [5] Tacrolimus Drug–Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin
    Morganne Sindelar
    Daniel McCabe
    Elisabeth Carroll
    Journal of Medical Toxicology, 2023, 19 : 45 - 48
  • [6] Phenytoin enzyme induction for management of supratherapeutic tacrolimus levels due to drug-drug interaction with nirmatrelvir/ritonavir: Case series and discussion
    Marsh, Jennifer
    Logan, Angela T.
    Bilgili, Erin P.
    Bowman, Lyndsey J.
    Webb, Allyssa R.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2024, 81 (13) : e345 - e352
  • [7] Experience of a nirmatrelvir/ritonavir drug-drug interaction expert advice service
    Lemaitre, Florian
    Tron, Camille
    Lalanne, Sebastien
    Franck, Benedicte
    Boglione-Kerrien, Christelle
    Taieb, Fabrice
    Verdier, Marie-Clemence
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 : 6 - 7
  • [8] Pharmacovigilance of Drug-Drug Interactions with Nirmatrelvir/Ritonavir
    Hendrick, Victoria
    Pohorylo, Erast
    Merchant, Lubna
    Gerhart, Jackie
    Arham, Iqra Naz
    Draica, Florin
    Quercia, Romina
    Ayoub, Ayman
    Mehta, Reema
    INFECTIOUS DISEASES AND THERAPY, 2024, 13 (12) : 2545 - 2561
  • [9] Nirmatrelvir/ritonavir: real world drug-drug interaction management experience
    Bukhari, Shahid
    Hughes, Stephen
    Mughal, Nabeela
    Moore, Luke S. P.
    Davies, Gary
    Zhang, Adrian Varghas
    Ng, Megan
    Karagozlu, Zekiye
    Boffito, Marta
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2024, 22 (09) : 781 - 783
  • [10] Nirmatrelvir+ritonavir/tacrolimus interactionAcute kidney injury and hyperkalaemia following drug-drug interaction: case report
    Reactions Weekly, 2022, 1936 (1) : 386 - 386
12345